Skip to main content

Advertisement

Log in

Health care in and outside a DMP for type 2 diabetes mellitus in Germany-results of an insurance customer survey focussing on differences in general education status

  • Original Article
  • Published:
Journal of Public Health Aims and scope Submit manuscript

Abstract

Aim

The Disease Management Programmes (DMPs) introduced in Germany since 2003 are intended to improve health care for the chronically ill. Whether they do this is currently being investigated in various evaluation settings. In order to assess possible changes in the process quality from the point of view of patients, the BARMER health insurance company conducted a national postal survey in Germany in 2007 of its customers with diabetes mellitus type 2 in order to compare programme participants and non-participants. This evaluation is a sub-analysis intended to clarify whether the utilisation, acceptability and perceived benefits of the programme differ as a result of educational status.

Subjects and Methods

A nationally representative random sample was drawn from BARMER insurance customers with type 2 diabetes, aged 45–79 years. Questionnaires were evaluated from 38.5% of the sample (DMP-participant respondents: n = 2,158; non-participant respondents: n = 2,182).

Results

A lower educational status was related among other things with increased morbidity, a poorer level of information and also a less well-developed “preventive attitude” to the disease. The finding that 49% of participants had a higher school qualification compared with 45% of non-participants, although significant, is less pronounced than the differences found between DMP participants and non-participants for other values analysed. A social influence could be found concerning the differences in treatment provided within the programme. A multivariate analysis shows that both the participation in the programme and higher levels of education have independent positive effects on the satisfaction with health status, with the effect of programme participation being stronger.

Conclusions

It can be assumed that the clear differences established between the groups of DMP participants and non-participants can in no way be explained solely by the comparatively small difference related to school education. Patients obviously appreciate the fact that the health personnel and the insurance company are paying increased interest to their disease, and this is true to an increased degree for participants with only basic schooling. Although overall this group is significantly under-represented among the participants, they reported to an increased degree that they were profiting from the programme.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Notes

  1. Standard instruments for evaluating health-related quality of life, such as SF 12 or SF 36 (Bullinger and Morfeld 2004), are not specifically designed with diabetes in mind. With no validated standards for diabetes-specific instruments (cf. Hirsch 1996, Altenhofen et al. 2005), items were included that were tailored to diabetes type 2.

  2. In addition, another type of standardisation was tested according to age and gender. Assuming that non-participants and participants would be similar in terms of both age and gender structure (which is not in fact the real situation, but which leads to full control of these factors), the non-participants were standardised separately to the participants for gender according to age. This led to slightly different values for proportions behind the decimal point without influencing the significance values determined.

References

  • Altenhofen L, Hagen B, Hass W (2005) Aspekte der Lebensqualität älterer Typ 2-Diabetiker-Ergebnisse aus einer Patientenbefragung unter Teilnehmern der Diabetes-Strukturvereinbarungen Nordrhein. In: Badura B, Iseringhausen O (eds) Wege aus der Krise der Versorgungsorganisation. Beiträge aus der Versorgungsforschung. Hans Huber Verlag, Bern, pp 238–254

    Google Scholar 

  • Altenhofen L, Hagen B, Hass W (2006) DMP Diabetes mellitus Typ 2-Was zeigen die bisherigen Ergebnisse aus Nordrhein? http://www.zi-berlin.de/dmp/downloads.php (08.03.2008)

  • Blumenstock G, Matziou P, Weigel I, Selbmann H-K (2006) Beschreibung der Diabetiker-Versorgung aus Patientensicht-Befragungsergebnisse im Diabetes-Modellvorhaben Südwürttemberg. Diabetes und Stoffwechsel 1(3):173–180

    Article  Google Scholar 

  • Bullinger M, Morfeld M (2004) Der Health Survey SF-36/SF-12: Darstellung und aktuelle Entwicklungen. In: Maurischat C, Morfeld M, Kohlmann T, Bullinger M, eds Lebensqualität: Nützlichkeit und Psychometrie des Health Survey SF-36/SF-12 in der medizinischen Rehabilitation. Pabst, Lengerich, pp 15–27

  • Busse R (2004) Disease Management programs in Germany’s statutory health insurance system. Health Aff 23(3):56–67

    Article  Google Scholar 

  • Dunkelberg S, Zingel D, Noack A, van den BH, Kaduszkiewitz H (2006) Welche Patienten werden (nicht) in das DMP Diabetes eingeschlossen? Gesundheitswesen 68:289–293

    Article  PubMed  CAS  Google Scholar 

  • Eichenlaub A, Steiner M (2005) Verbesserte Diabetikerversorgung in Sachsen-Anhalt. Ergebnisse der Evaluation des Diabetes Modellprojektes (1. Quartal 2001 bis 4. Quartal 2002). Zeitschrift für ärztliche Fortbildung und Qualitätssicherung im Gesundheitswesen 99(3):191–195

    Google Scholar 

  • Eller M, Satzinger W, Holle R, Meisinger C, Thorand B (2005) Disease-Management-Programme in Deutschland: Erste Reaktionen der Diabetiker. Gesundheitswesen 67, Special Issue 1:144–149

  • Elkeles T, Heinze S, Eifel R (2007) Healthcare by a DMP for Diabetes mellitus Type 2-Results of a survey of participating insurance customers of a health insurance company in Germany. J Publ Health 15(6):473–80

    Article  Google Scholar 

  • Elkeles T, Kirschner W, Graf C, Kellermann-Mühlhoff P (2008) Versorgungsunterschiede zwischen DMP und Nicht-DMP aus Sicht der Versicherten. Ergebnisse einer vergleichenden Versichertenbefragung von Typ 2-Diabetikern der BARMER. Gesundheits- und Sozialpolitik 62(1):10–18

    Google Scholar 

  • Faller H (2006) Patientenorientierung im Gesundheitswesen: Arzt-patient-beziehung, shared decision making, empowerment. In: Pawils S, Koch U (eds) Psychosoziale Versorgung in der Medizin. Entwicklungstendenzen und Ergebnisse der Versorgungsforschung. Schattauer, Stuttgart, pp 74–84

  • Gerlach FM, Beyer M, Szecsenyi J, Raspe H (2003) Evaluation von Disease-Management-Programmen-Aktuelle Defizite, Anforderungen, Methoden. Zeitschrift für ärztliche Fortbildung und Qualitätssicherung im Gesundheitswesen 97:495–501

    Google Scholar 

  • Graf C (2006) Disease Management Programme und Integrierte Versorgung. Gesundheits- und Sozialpolitik 60(5–6):42–52

    Google Scholar 

  • Graf C, Ullrich W, Marschall U (2008) Nutzenbewertung der DMP Diabetes mellitus? Neue Erkenntnisse aus dem Vergleich von DMP-Teilnehmern und Nichtteilnehmern anhand von GKV-Routinedaten und einer Patientenbefragung. Gesundheits- und Sozialpolitik 62(1):19–30

    Google Scholar 

  • Grogan S, Conner M, Norman P, Willits D, Porter I (2000) Validation of a questionnaire measuring patient satisfaction with general practitioner services. Qual Health Care 9:210–215

    Article  PubMed  CAS  Google Scholar 

  • Hall JA, Dornan MC (1988) Meta-analysis of satisfaction with medical care: description of research domain and analysis of overall satisfaction levels. Soc Sci Med 27(6):637–644

    Article  PubMed  CAS  Google Scholar 

  • Häussler B, Wille E, Wasem J, Storz P (2005) Diabetiker im Disease Management. Erste Erkenntnisse über die Wirkung der Disease Management Programme in der gesetzlichen Krankenversicherung. Gesundheits- und Sozialpolitik 59(9–10):23–33

    Google Scholar 

  • Hirsch A (1996) Diabetes und Lebensqualität. In: Petermann F (ed) Lebensqualität und chronische Krankheit. Dustri, München, pp 185–222

    Google Scholar 

  • Joos S, Rosemann T, Heiderhoff M, Wensing M, Ludt S, Gensichen J, Kaufmann-Kolle P, Szecsenyi J (2005) ELSID-Diabetes study-evaluation of a large scale implementation of disease management programmes for patients with type 2 diabetes. Rationale, design and conduct-a study protocol. BMC Public Health 5:99

    Article  PubMed  Google Scholar 

  • Knight K, Badamgarav E, Henning JM, Hasselblad V, Gano AD Jr, Ofman JJ, Weingarten SR (2005) A systematic review of diabetes disease management programs. Am J Manag Care 11(4):242–250

    PubMed  Google Scholar 

  • Lippmann-Grob B, Bierwirth RA, Kron P, Leinhos B, Funke K, Huptas M, Grüneberg M, Weich KW, Münscher C, Potthoff F (2003) Patientenklassifikation und Risikoprofilanalysen bei Typ-2-Diabetikern in der Schwerpunktpraxis. Ergebnisse der TEMPO-Studie. Deut Med Wochenschr 129:75–81

    Article  Google Scholar 

  • Lippmann-Grob B, Hillenbrand H, Kolonko B, Vogelmann M (2006) Diabetikerversorgung in Baden-Württemberg. Messung der Versorgungsqualität mittels Patientenbefragung im Rahmen des Projektes “Regionale Versorgungsqualität der Arbeitsgemeinschaft Diabetologie Baden-Württemberg (ADBW)”. Diabetes, Stoffwechsel und Herz 15(1):21–28

    Google Scholar 

  • Miksch A, Hermann K, Trieschmann J, Roelz A, Heiderhoff M, Laux G, Rosemann T, Szeczenyi J (2008) Gender-specific differences in quality of life of patients with type 2 diabetes with or without participating in DMP. Gesundheitswesen 70:250–255

    Article  PubMed  CAS  Google Scholar 

  • Morfeld M, Koch U (2005) Ansprüche an die Evaluation komplexer Gesundheitsprogramme-Disease-Management-Programme in Deutschland. Zeitschrift für ärztliche Fortbildung und Qualitätssicherung im Gesundheitswesen 99(3):179–184

    Google Scholar 

  • Robinson R, Steiner A (1998) Managed health care: US evidence and lessons for the National Health Service. Open University Press, Buckingham

    Google Scholar 

  • Rothe U, Müller G, Schwartz PE, Seifert M, Kunath H, Koch R, Bergmann S, Julius U, Bornstein SR, Hanefeld M, Schulze J (2008) Evaluation of a diabetes management system based on practice guidelines, integrated care and continuous quality management in a federal state of germany: a population-based approach to health care research. Diabetes Care 31:863–868

    Article  PubMed  Google Scholar 

  • Saltman R, Otter Cv (1995) Implementing planned markets in health care. Open University Press, Buckingham

    Google Scholar 

  • Selby JV, Scanlon D, Lafata JE, Villagra V, Beich J, Salber PR (2003) Determining the value of disease management programs. Joint Commission journal on quality and safety 29(9):491–499

    PubMed  Google Scholar 

  • Scheibler F, Pfaff H eds (2004) Shared decision-making: von der Compliance zur partnerschaftlichen Entscheidungsfindung. Hans Huber Verlag, Bern [et al.]

  • Sidorov J, Shull R, Tomcavage J, Girolami S, Lawton N, Harris R (2002) Does Diabetes Disease Management save money and improve outcomes? Diabetes Care 25 4:684–689

    Article  Google Scholar 

  • Szecsenyi J, Rosemann T, Joos S, Klimm FP, Miksch A (2008) German diabetes disease management programmes are appropriate to restructure care according to the Chronic Care Model. An evaluation with the Patient Assessment of Chronic Illness Care (PACIC-5A) instrument. Diabetes Care 31(6):1150–1154

    Article  PubMed  Google Scholar 

  • Schunk M, Schweikert B, Gapp O, Reitmeir P, Meisinger C, Mielck A, Holle R (2007) Zeitliche Veränderungen in Versorgung und Krankheitsmanagement von Diabetes Typ 2 - Patienten zwischen 1997 und 2005. Analyse zweier bevölkerungsbasierter Studien (KORA Augsburg). In: Wichmann H-E, Nowak D, Zapf A, eds. Kongress Medizin und Gesellschaft 2007, Augsburg 17.-21.September 2007, Abstractband. Rheinware Verlag, Mönchengladbach, p 322

  • SVR (Sachverständigenrat zur Begutachtung der Entwicklung im Gesundheitswesen) Kooperation und Verantwortung. Voraussetzungen einer zielorientierten Gesundheitsversorgung. Gutachten 2007

  • Todd WE, Nash D (eds) (1997) Disease management: a systems approach to improving patient outcomes. American Hospital Pub, Chicago

  • Ullrich W, Marschall U, Graf C (2007) Versorgungsmerkmale des Diabetes mellitus in Disease-Management-Programmen. Ein Vergleich von in die DMP eingeschriebenen und nichteingeschriebenen Versicherten mit Diabetes. Diabetes, Stoffwechsel und Herz 16:407–414

    Google Scholar 

  • Veeder NW, Peebles-Wilkins W (2001) Managed care services: policy, programs, and research. Oxford University Press, New York

    Google Scholar 

  • Wegscheider K, Romes C, Gawlik C (2006) Evaluation von Disease Management Programmen in Deutschland. In: Göpffarth D, Greß S, Jacobs K, Wasem J (eds) 10 Jahre Kassenwahlfreiheit. Jahrbuch Risikostrukturausgleich 2006. Asgard, St. Augustin, pp 261–278

  • Weingarten SR, Henning JM, Badamgarav E, Knight K, Hasselblad V, Gano A Jr, Ofman JJ (2002) Interventions used in disease management programmes for patients with chronic illness - which one works? Meta-analysis of published reports. Br Med J 325(26):925–927 October

    Article  Google Scholar 

Download references

Conflict of interest

The authors disclose any relevant associations that might pose a conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas Elkeles.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elkeles, T., Kirschner, W., Graf, C. et al. Health care in and outside a DMP for type 2 diabetes mellitus in Germany-results of an insurance customer survey focussing on differences in general education status. J Public Health 17, 205–216 (2009). https://doi.org/10.1007/s10389-008-0234-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10389-008-0234-5

Keywords

Navigation